Qiao et al. also included a large meta-analysis of 13 studies [58,109,118,120,122,124,126,127,129,130,132,133,135] that involved 2792 MDD patients and 1146 controls, concluding that IGF-1 levels are significantly increased in MDD patients [131]. This evidence concerns the gene IGF1 and major depressive disorder.